Nordic Procurement Deal Signals New Weapons In Fight For Lower Prices
Executive Summary
A new joint procurement agreement between Norway and Denmark is a signal to drug companies that they will have to increasingly negotiate with more than one country in a new age of collaboration, says Amgros, the Danish medicines procurement agency.
You may also be interested in...
Joint Tendering Creates ‘Attractive Nordic Market’
Joint tendering among Nordic countries can help reduce shortages of older, off-patent medicines.
European Cross-Country Pricing Collaborations Gather More Steam
Iceland has joined the Denmark-Norway pricing alliance while Denmark could soon join the BeNeLuxAI collaboration.
Vertex Extends Portfolio Pricing and Reimbursement Approach To Denmark
Vertex has succeeded in bringing its portfolio-based approach to the pricing and reimbursement of its cystic fibrosis treatments to another market, Denmark. This follows similar deals in Ireland and Sweden.